AstraZeneca & Nektar Ink Deal on Drug Development

AstraZeneca (AZN) and Nektar Therapeutics (NKTR) have agreed to a deal in which AstraZeneca will ...  More »

AstraZeneca (AZN) and Nektar Therapeutics (NKTR) have agreed to a deal in which AstraZeneca will pay Nektar $125 million upfront for the rights to two drugs. One of the drugs treats constipation related to opioid drugs and the other combines the first drug with opioids to create a non-constipating painkiller.  « Less